GB8400863D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB8400863D0
GB8400863D0 GB848400863A GB8400863A GB8400863D0 GB 8400863 D0 GB8400863 D0 GB 8400863D0 GB 848400863 A GB848400863 A GB 848400863A GB 8400863 A GB8400863 A GB 8400863A GB 8400863 D0 GB8400863 D0 GB 8400863D0
Authority
GB
United Kingdom
Prior art keywords
compounds
chemical compounds
formula
hydrogon
bronchodilating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB848400863A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB848400863A priority Critical patent/GB8400863D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB8400863D0 publication Critical patent/GB8400863D0/en
Priority to JO19851351A priority patent/JO1351B1/en
Priority to ZW3/85A priority patent/ZW385A1/xx
Priority to CA000471594A priority patent/CA1251209A/en
Priority to DK009185A priority patent/DK162519C/da
Priority to PH31697A priority patent/PH22136A/en
Priority to PT79819A priority patent/PT79819B/pt
Priority to IL74031A priority patent/IL74031A/xx
Priority to DD85272500A priority patent/DD231350A5/de
Priority to GR850068A priority patent/GR850068B/el
Priority to CS85202A priority patent/CS248731B2/cs
Priority to ES539446A priority patent/ES8607949A1/es
Priority to NO850129A priority patent/NO850129L/no
Priority to JP60003912A priority patent/JPS60158181A/ja
Priority to PL1985251516A priority patent/PL147123B1/pl
Priority to AU37611/85A priority patent/AU572252B2/en
Priority to DE8585300196T priority patent/DE3564941D1/de
Priority to NZ210816A priority patent/NZ210816A/en
Priority to AT85300196T priority patent/ATE37179T1/de
Priority to ZA85251A priority patent/ZA85251B/xx
Priority to PCT/GB1985/000014 priority patent/WO1985003076A1/en
Priority to FI850140A priority patent/FI850140L/fi
Priority to IE69/85A priority patent/IE57969B1/en
Priority to EP85300196A priority patent/EP0150937B1/en
Priority to HU85109A priority patent/HU193591B/hu
Priority to KR1019850000179A priority patent/KR920006781B1/ko
Priority to US06/690,911 priority patent/US4654342A/en
Priority to CN198585101722A priority patent/CN85101722A/zh
Priority to SU853958649A priority patent/SU1396963A3/ru
Priority to RO85120090A priority patent/RO92607A/ro
Priority to ES549629A priority patent/ES8703846A1/es
Priority to ES554965A priority patent/ES8706645A1/es
Priority to MYPI87000758A priority patent/MY100124A/en
Priority to JP63113410A priority patent/JPS63313775A/ja
Priority to JP63113411A priority patent/JPS63313776A/ja
Priority to CA000581012A priority patent/CA1260471A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
GB848400863A 1984-01-13 1984-01-13 Chemical compounds Pending GB8400863D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds
JO19851351A JO1351B1 (en) 1984-01-13 1985-01-02 Chemical compounds
ZW3/85A ZW385A1 (en) 1984-01-13 1985-01-07 Chemical compounds
CA000471594A CA1251209A (en) 1984-01-13 1985-01-07 DISHYDROPYRIDAZINONE DERIVATIVES
DK009185A DK162519C (da) 1984-01-13 1985-01-08 Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne
PH31697A PH22136A (en) 1984-01-13 1985-01-09 Dihydropyridazinone derivatives and use thereof
ES539446A ES8607949A1 (es) 1984-01-13 1985-01-10 Un procedimiento para preparar un derivado de dihidropiridazinona
PT79819A PT79819B (en) 1984-01-13 1985-01-10 Process to prepare dihydropiridazinone derivatives its salts and pharmaceutical compositions and intermediate compounds there with
IL74031A IL74031A (en) 1984-01-13 1985-01-10 6-(4-(n-cyanoguanidino)phenyl)-4,5-dihydro-3(2h)-pyridazinone derivatives,their preparation and pharmaceutical compositions containing them
DD85272500A DD231350A5 (de) 1984-01-13 1985-01-10 Verfahren zur herstellung von 6-phenyl-4,5-dihydro-3(2h)-pyridazinon-verbindungen und ihren salzen
GR850068A GR850068B (enExample) 1984-01-13 1985-01-10
CS85202A CS248731B2 (en) 1984-01-13 1985-01-10 Production method of the phenyl dihydropyridazinon derivatives
ZA85251A ZA85251B (en) 1984-01-13 1985-01-11 Chemical compounds
DE8585300196T DE3564941D1 (en) 1984-01-13 1985-01-11 Dihydropyridazinones
HU85109A HU193591B (en) 1984-01-13 1985-01-11 Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent
PL1985251516A PL147123B1 (en) 1984-01-13 1985-01-11 Method of obtaining novel derivatives of dihydropyridazinone
AU37611/85A AU572252B2 (en) 1984-01-13 1985-01-11 5-methyl-4,5 dihydro-3(2h) pyridazinone derivatives
NO850129A NO850129L (no) 1984-01-13 1985-01-11 Fremgangsmaate for fremstilling av terapeutisk aktive dihydropyridazinon-derivater
NZ210816A NZ210816A (en) 1984-01-13 1985-01-11 Dihydropyridazinones and pharmaceutical compositions
AT85300196T ATE37179T1 (de) 1984-01-13 1985-01-11 Dihydropyridazinone.
JP60003912A JPS60158181A (ja) 1984-01-13 1985-01-11 ジヒドロピリダジノン誘導体
PCT/GB1985/000014 WO1985003076A1 (en) 1984-01-13 1985-01-11 Dihydropyridazinones
FI850140A FI850140L (fi) 1984-01-13 1985-01-11 Kemiska foereningar.
IE69/85A IE57969B1 (en) 1984-01-13 1985-01-11 Dihydropyridazinones
EP85300196A EP0150937B1 (en) 1984-01-13 1985-01-11 Dihydropyridazinones
KR1019850000179A KR920006781B1 (ko) 1984-01-13 1985-01-12 디하이드로 피리다진온 유도체를 제조하는 방법
US06/690,911 US4654342A (en) 1984-01-13 1985-01-14 6-(cyanoguanidinophenyl)pyridazinones as cardiac stimulants
CN198585101722A CN85101722A (zh) 1984-01-13 1985-04-01 制备二氢哒嗪酮衍生物的方法
SU853958649A SU1396963A3 (ru) 1984-01-13 1985-09-12 Способ получени производных дигидропиридазинона
RO85120090A RO92607A (ro) 1984-01-13 1985-09-12 Procedeu pentru prepararea unor derivati de dihidropiridazinona
ES549629A ES8703846A1 (es) 1984-01-13 1985-12-05 Un procedimiento para preparar derivados de dihidropiridazi-nona
ES554965A ES8706645A1 (es) 1984-01-13 1986-05-14 Un procedimiento para preparar derivados de dihidropiridazinona
MYPI87000758A MY100124A (en) 1984-01-13 1987-06-02 Dihydropyridazinones.
JP63113410A JPS63313775A (ja) 1984-01-13 1988-05-09 ジヒドロピリダジノン誘導体
JP63113411A JPS63313776A (ja) 1984-01-13 1988-05-09 ジヒドロピリダジノン誘導体
CA000581012A CA1260471A (en) 1984-01-13 1988-10-21 Dihydropyridazinone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (1)

Publication Number Publication Date
GB8400863D0 true GB8400863D0 (en) 1984-02-15

Family

ID=10554924

Family Applications (1)

Application Number Title Priority Date Filing Date
GB848400863A Pending GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Country Status (31)

Country Link
US (1) US4654342A (enExample)
EP (1) EP0150937B1 (enExample)
JP (3) JPS60158181A (enExample)
KR (1) KR920006781B1 (enExample)
CN (1) CN85101722A (enExample)
AT (1) ATE37179T1 (enExample)
AU (1) AU572252B2 (enExample)
CA (2) CA1251209A (enExample)
CS (1) CS248731B2 (enExample)
DD (1) DD231350A5 (enExample)
DE (1) DE3564941D1 (enExample)
DK (1) DK162519C (enExample)
ES (3) ES8607949A1 (enExample)
FI (1) FI850140L (enExample)
GB (1) GB8400863D0 (enExample)
GR (1) GR850068B (enExample)
HU (1) HU193591B (enExample)
IE (1) IE57969B1 (enExample)
IL (1) IL74031A (enExample)
JO (1) JO1351B1 (enExample)
MY (1) MY100124A (enExample)
NO (1) NO850129L (enExample)
NZ (1) NZ210816A (enExample)
PH (1) PH22136A (enExample)
PL (1) PL147123B1 (enExample)
PT (1) PT79819B (enExample)
RO (1) RO92607A (enExample)
SU (1) SU1396963A3 (enExample)
WO (1) WO1985003076A1 (enExample)
ZA (1) ZA85251B (enExample)
ZW (1) ZW385A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU2002254124A1 (en) 2001-02-27 2002-09-12 Mitokor Aryl-n-cyanoguanidines and methods related thereto
DE60213841T2 (de) * 2001-11-05 2007-02-15 Merck Patent Gmbh Hydrazono-malonitrile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) * 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
PL1951227T3 (pl) * 2005-11-14 2017-09-29 Boehringer Ingelheim Vetmedica Gmbh Zastosowania pimobendanu do leczenia bezobjawowej(utajonej) niewydolności serca
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8664252B2 (en) 2008-11-25 2014-03-04 Boehringer Ingelheim Vetmedica Gmbh Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
PL3021832T3 (pl) 2013-07-19 2021-08-23 Boehringer Ingelheim Vetmedica Gmbh Konserwowana ciekła wodna kompozycja farmaceutyczna zawierająca eteryfikowane pochodne cyklodekstryny
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
BR122019024673B1 (pt) 2013-12-04 2023-04-11 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
EP0030835B1 (en) * 1979-12-05 1983-05-11 Morishita Pharmaceutical Co. Ltd. Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them
EP0059688B1 (de) * 1981-03-04 1985-05-15 Ciba-Geigy Ag Pyridazinone, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen und deren Verwendung
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones

Also Published As

Publication number Publication date
US4654342A (en) 1987-03-31
NZ210816A (en) 1987-06-30
KR850005417A (ko) 1985-08-26
DD231350A5 (de) 1985-12-24
JO1351B1 (en) 1986-11-30
WO1985003076A1 (en) 1985-07-18
KR920006781B1 (ko) 1992-08-17
JPS63313776A (ja) 1988-12-21
FI850140A0 (fi) 1985-01-11
JPS60158181A (ja) 1985-08-19
CA1260471C (enExample) 1989-09-26
CS248731B2 (en) 1987-02-12
ES8706645A1 (es) 1987-07-01
GR850068B (enExample) 1985-05-03
ES554965A0 (es) 1987-07-01
ES8607949A1 (es) 1986-06-01
SU1396963A3 (ru) 1988-05-15
DK162519B (da) 1991-11-11
DK9185A (da) 1985-07-14
FI850140A7 (fi) 1985-07-14
IE57969B1 (en) 1993-06-02
IL74031A (en) 1988-07-31
ZA85251B (en) 1986-08-27
DK162519C (da) 1992-03-30
ES539446A0 (es) 1986-06-01
CA1260471A (en) 1989-09-26
PL251516A1 (en) 1985-12-17
RO92607A (ro) 1987-11-30
IE850069L (en) 1985-07-13
PL147123B1 (en) 1989-04-29
DE3564941D1 (en) 1988-10-20
ZW385A1 (en) 1985-08-07
ATE37179T1 (de) 1988-09-15
AU3761185A (en) 1985-07-18
PH22136A (en) 1988-06-01
JPS63313775A (ja) 1988-12-21
EP0150937A3 (en) 1985-08-21
AU572252B2 (en) 1988-05-05
CN85101722A (zh) 1987-01-31
CA1251209A (en) 1989-03-14
IL74031A0 (en) 1985-04-30
FI850140L (fi) 1985-07-14
HUT37128A (en) 1985-11-28
EP0150937A2 (en) 1985-08-07
NO850129L (no) 1985-07-15
MY100124A (en) 1989-12-18
ES8703846A1 (es) 1987-03-01
HU193591B (en) 1987-11-30
EP0150937B1 (en) 1988-09-14
PT79819A (en) 1985-02-01
ES549629A0 (es) 1987-03-01
PT79819B (en) 1987-01-07
DK9185D0 (da) 1985-01-08

Similar Documents

Publication Publication Date Title
ZA85251B (en) Chemical compounds
EP0233745A3 (en) Chemical compounds
GB2071098B (en) Dibenzocycloheptenylidenes and antiinflammatory compositions
PT84760A (en) Heterocyclic compounds
NZ216741A (en) 6-oxo-1,6-dihydropyridazines and pharmaceutical compositions